by James Radke, PhD | Apr 11, 2025
A recent study evaluated outcomes of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) patients treated with R-GemOx. DLBCL is a form of non-Hodgkin lymphoma. Lymphomas occur when cells of the immune system, B lymphocytes, grow and multiply uncontrollably....
by Madaline Spencer | Mar 31, 2025
A recent study analyzed the incidence and characteristics of cutaneous squamous cell carcinoma (cSCC) in patients with Sézary syndrome. Sézary syndrome is a rare, aggressive form of cutaneous T-cell lymphoma (CTCL), a group of rare cancers that occur when T-cells...
by Madaline Spencer | Mar 24, 2025
Alessandra Maleddu, MD, Sarcoma Specialist at the University of Colorado, discusses the misdiagnosis of desmoid tumors and provides some resources for patients. Desmoid tumors are rare, benign, locally invasive, soft tissue tumors. They are commonly...
by Madaline Spencer | Feb 20, 2025
Jorge Cortes, MD, Director of the Georgia Cancer Center, discusses five year follow-up results of the OPTIC clinical trial for chronic myeloid leukemia (CML). CML is a myeloproliferative neoplasm characterized by the expression of the BCR-ABL1 fusion...
by Madaline Spencer | Feb 14, 2025
Carsten Utoft Niemann, MD, PhD, Copenhagen University Hospital, discusses results from the GLOW clinical trial in chronic lymphocytic leukemia (CLL). CLL is a rare cancer of the lymphocytes. Early signs and symptoms may include swollen lymph nodes,...
